SAPHIR registry for advanced stomach and esophagus cancer
Part of Cancer, Digestive system clinical trials.
This registry collects information from people with stage IV (metastatic) stomach or esophagus cancers who are about to start their first medicines to control the disease. It may help researchers understand which treatments are used and how patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV (metastatic) esophagus, junction, or stomach cancer (ESCC, EAC, GAC, or GEJAC) confirmed by tissue testing
- You are planning to start palliative systemic treatment as your first treatment (meaning medicines to treat the whole body)
- You are 18 years old or older
- You can sign informed consent for the study (questionnaires may require consent before treatment or within 4 weeks after starting, depending on your participation)
- You must not be receiving no systemic (whole-body) therapy for your cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps an organized record of people diagnosed with esophagus, gastroesophageal junction, or stomach cancer. It helps researchers learn from real-world outcomes, based on health information collected over time.
This registry collects information about people with advanced pancreatic cancer who are receiving first-line palliative treatment. It helps doctors understand which treatment choices are used and how people do over time.
This trial is a cancer data and blood-sample registry. It collects information from people newly diagnosed with esophagus or stomach (or the stomach–esophagus junction) cancer to help researchers understand treatment patterns and outcomes.
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
This study is a registry that collects information about people who need an endoscopy procedure. It may help doctors learn which approaches work best and improve care over time.
This study enrolls healthy adults to build a registry and biobank (collection of samples). It tests whether collecting information and biological samples from people without symptoms can help researchers understand normal stomach and esophagus function.
Hear when a new Esophageal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.